{"ticker": {"uuid": "4bf4d06a-3706-42b1-a96d-12a632d079b8", "symbol": "0867", "name": "China Medical System Holdings Limited", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "China Medical System Holdings Ltd. Actuals & Estimates (HKEX:867)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNMmVmVkQtRlNmbUhFNExDMjd3eGQzM091X0dHemhDQUZiWHQ3bXMwam5DdHBJUkVaaDlveElsWFdIMGxPekhmbGd6Q3ZVVnBLS0RNREtzaXpFMDhad1JudVZVczMwY3VuV3BZaDJVVks4UHZkY05hNzBXc2FXZldRSkRB?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T13:34:15+00:00", "published_display": "04 Jul 2026 13:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How NMPA Approval of First-in-Class Rabies Antibody Will Impact China Medical System (SEHK:867) Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxOWGFqVnA0OGJxWngtNVAxclVuZnZWNUtKZzYtZHhYZmhrMENkN25qR2RscV9yY3pSS09yVDhWTzFQdWhaLTVTX3k1Q3NMVF9pVWpZcFdrenVfdmdZdFFYSFBGY3ByVlhqYXFNMzl1Qi11Nk5NdDh4M2FGY2Y1dGNmSndZaWxFcWdSc3Z4VExKTXZvRXVFT3lpNFRoSktYOUFrZ1ZYNkVsVmxQZm0tdGpKUVlmblZkcENUeDJkQ19zZUloSy1RRzlGd3l5U3I2V1BpODIyRmVMRDcyM2FFSG9nbmgxOWFJNnRmb0RVWE5nLTBmQTFMU29GczF30gH_AUFVX3lxTE14TUptdHBtMXgwUG9qUFE0N3FqOUlWOXVZdDJHdU1JMzZQaUp3S2pmeDRLQ0V3NGxLYXYycHJwbzdqdERXczY3bkJFX2dnYWpRZW8weTdia2dwd3cwYnVEN2pKWVl4a3lRdjliQ0xkV2ZRMTNremhVanc0dDdYT2M1VllTRVdGaktyMF9rWXRKR29BX0lnTjVwdFZJcTc4djVXT0NFeWliVTJDR2J2MVMzWmlHN3RiMWlmRmcxQ2ZHdGt4UVVON3FiNndhN3h3cUUyNi03Q05kanB0RDZ1MS1iRWxJdlEzZDJESnJkTXNVUGRsbHdOeTE0cUF3VGJxbw?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System Holdings (SEHK:867) Stock Could Be Below Fair Value After CMS D008 Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxNQXBJdzBMZW1DSGNkMFA1N2ZMcXVWRDlFWUtXMXlGTjRkRnlLM3J4OEhTOGdVbkF5OUh2eDZ4WkNTUjNldDMtLVNpb2psU2pZRGlzYkV2Y2t5ZmFfWnk2Tl9BOHFCbTIzcDNtaGx3SW00aVZ3NnpfbklrcUpwcDJudFcwMjZadGV4MFBOX2F4NnozTjdpbHphQjMyMU5pOWM3RkZvVzA3cjZONHJaTy1OWTFIUjI0NE9qckVuYlB5R2oteVVpZzdQcnhxb2JBVzdES3ZiLWJFNkpReV9WRjRqWnhhN3JoR2hwUE5Id2I2LUVIeHhHMFJkQ0pR0gH_AUFVX3lxTE05R0lfSG40VVlWWWR1Z2l6Ql83a2luZVpWX3pIN2MzQXhrU0MzMGU1VXhtY3ljUk1KVDhRX0tPUGdrbVdELWFNVklTVjRPcEtuSUd3UGw0OUxsa296NVJSRGQzZXdIX0dEanBlWlA5NGVVWC1ZNVVodXF5THVqTU5scWJnQ2RPb1ZWeDBBMVc2TlVpUzhZRTFpejl4VldqWVBKTk5EUUVWMnR5NHlGT1ZPTVpZVjFqMWhGbFN0NHRnRmJreDRfdm5wYTJYNkZsOEdNQVQ2U0hPNFZjUjQ2ZlFodWVYdUNWbnVMTVdBYkV4RkdURzdfZlI0VTJfY1pvZw?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System Stock - analyst consensus and strategy snapshot", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPVTN2YUFybXJLUHpfeXBESDQtbWVjSHNsNUFDOTBYSHpHWGlfWVpFSUdqeWRiUUdZYnp1amNLbTE1STNWTm5aNTBydTJUb2ZwNTlCblROMUE3bU92blZVM3FxSGJKS3R6a0lseFZWaGlSX3V4VXhieUZYN0pMaXI5WENkYm1TaUFmRUJGUFpqeWtuNlhjN05LbjcwcTQxTkhLUzlsMThCT0d2X1pxM09ydDdWdkZuNzBkM2JtekpiOW1nZDg?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-17T15:29:30+00:00", "published_display": "17 Jun 2026 15:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zydus Lifesciences' Desidustat Receives NMPA Approval for Renal Anaemia Treatment in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxON0FEcU5fN19mdzhQbjY1cF81aHlJVU45UnlpajZKQkVVa3puSGVqcnlrNTB2bUxCdW9RSHQwSDZ3YjR5X21YakV2WDY0Y1pjb3psd2IwamtHR0xrV1BtVW9Mc0IyVXpqbEl6WVdmWi13NGlMMGNMd2VST1pzUkYwSW9HekE3R1dmNm9yeTVINGJOVmstNlBzRmNVb3h4MW82MjI1QU90empoNXhVcGhPLTVRUWhDU2ExMUdMa2k4cFIzaEVKam5seDFWeXY3TlZsdTc4anREZzJ4R2s2QUdr?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-15T07:00:00+00:00", "published_display": "15 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deloitte China assists listings of PATEO and HIPINE on SEHK", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOamZocWNsbkI2S19CeTZZd3JqamFRdGVpOEpmdXBJSGNBOGpHOTNUZk9GUnRrazFxMnB2UU9ocXBva3l3TThMQ2NuOU1YaTJ0ajVwSlpQSHZjblBoakwtaVVNV1JNNW9GZnkxdzVYdDlvVDBZVEJWNVZfSnJHd0Y4TzFIMkswcW9ERkpOSUY0V1h1RXQ3bkplUnpuNTF3VXFTRjItdTRPTQ?oc=5", "source_name": "Deloitte", "published_at": "2025-09-30T12:42:17+00:00", "published_display": "30 Sep 2025 12:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deloitte China assists dual-primary listing of Hesai Group in SEHK", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPREpOdk5PUmZLZ3pZZTlySkdaR1ZtaDdBdGxsSzVFVnNleWdZVHc3UXZRc2hfdU1YQjJWYWJ6VjNVUk9Nd2s3cUVTcDV6Sm1WaEQ3N1Q1eFBzM0JTbEpQbjQ2MjNPQURNNnIyMGZVbUZkNTlGTkdhaWFwZlMxclg2Z2xkUmxjamx3YTJadjY4dVR0RXVwTkNDZG9iX0c3cXhpcVlrT2FwdVB6aEItQW1qYm1LaS1YS19vVnBB?oc=5", "source_name": "Deloitte", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System\u2019s Alzheimer\u2019s Drug ZUNVYL Gains Approval in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPVXNfTU1sWnZpVXdMcjFySU9SNW92ajBmRGc5MzlxYTRUWGt0MmNLdkY1eEQ2VU5KY3J5emoxWjNDX2pGN1NUOEFlWFVISU0zLXJkeGE1cFVmNUYzdlBHZFFQdFV1bnJIcWcydVpXbTdacVBHcV9NOUlUbW1uMDlRemdxeENpRjJCSVJtRFVtR3prbkh1cEhweW5YYnF0SElrLTU1dXRBRmFOZ1Jwb3loLXhoTHdHV1V4R3ZoRQ?oc=5", "source_name": "TipRanks", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System debuts on SGX", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE11eWNVRHd5UFNIeGVKQlp6XzBzc0ZaR0ozdzZYYlhrYXRObXh3cUY2V2FvWHNjaTFBcWxZS2FlWTFubzd1WUphUzBxcTV4ZW1RQk1nalMwcmhhZmVQSlBEaFJPNUtKUmN0OEYxbWlWN29lQ2xna3dRLUZuc2JEQQ?oc=5", "source_name": "Singapore Business Review", "published_at": "2025-07-16T07:00:00+00:00", "published_display": "16 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System shares surge 11% with its secondary listing on SGX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPejNZbHk4UWJGcnNoRE9TUjZMU0E2cVRwTS1CS0JvS3FDMjBUUEZ2akxlY2oybG81aG4tbjFZdjRJRVhGWEtVeWdJQW0wUGkzNkZQVlkyUHFxajQzeGVVY3gtTE1OY3VDd3VPZVBQYXp0TUV0eVBDQ25HSWxnakJXaGZQMTJXYVZqT25ySmU4Q1hKVGQ0SjdkOXRmNFVXVTR3WU9LUGF4Vjg2WTdrcFhkdmRmdw?oc=5", "source_name": "The Business Times", "published_at": "2025-07-15T07:00:00+00:00", "published_display": "15 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System shares rise 11% with its secondary listing on SGX", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQZWNiWTdDeTBMWnFRSGVnX3BEWnlSTElfa3A2Q0hVOTVJbVJkMFNFM1lrWFJKcURqdFBvTEhoUy1OX2JoTjZXcElCdmJEWXl6cnU4Ykw3cjcwSDhqU2hkQmxRQXBWdkRMMkthY1RMcEgwd1Y0S1NJOGxULXdHQnpiMkRONl9HSVlZVTJPVTZYVlNoQzNqN044QU5Takw2VHpRaUtZM3dmVHo2UVVjem9xeGVrY2pGa0tmd0xqdVo2YjdNTlFa?oc=5", "source_name": "The Straits Times", "published_at": "2025-07-15T07:00:00+00:00", "published_display": "15 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deloitte China assists secondary listing of China Medical System on SGX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPTkVMSVpWMGlLcW8tQTEzY0tOcVhVdFRsTW9tR0tFOTN0LUhxWTc0ZVJURWdCNUdwVzVwSk5sUW1ZdVdtN25MeGxGNXBtTGVMbzNUZEctWjFXYnpEOVlneUdZa08wNmoyT29GeUV2UENwQVh6aC12VlpkVXNuNmx4TkVtV0ROcXgzSTlaM1dNVW1paW92ZXVxVWotV2gyWm9QOGxuelBEc3BSbjZybDBZS2dsNVdvaWdQNXFhblZVZnY2dw?oc=5", "source_name": "Deloitte", "published_at": "2025-07-15T07:00:00+00:00", "published_display": "15 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System eyes secondary listing on SGX in July", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPLXdCU3Y0QzZabGd3Q3lOSlp2VHlwRnRIV3FjNzFseXF2MFR0SVBjeFdMN1ZvdjFxOWFPY00wdkdETmFqNmhOdGV2OENDcjhRRWlEODdHcDRNLXdINUc2TmZSZGN4WV9scW5GR2lwR3Y3M1p6V3V0eUswdVdGRDdFQmpPWEJHMGZqZko0eUlnNnozWnAtWm1yQnA1V0U2QQ?oc=5", "source_name": "Singapore Business Review", "published_at": "2025-06-30T07:00:00+00:00", "published_display": "30 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong-listed China Medical System seeks secondary listing on SGX", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPODR3SE80RWJwMl9jd1RCTmlpOWY5SWVtX0FWdl91a2MzcXduLVRQSGhPOFQ5bTZPVE4ycmpzZFRuRTVPYV93WlJSbWN5cDdZVnhqTU4zVlktZHRoRWhjYUhyV0VXRUNVNUwweGJCNENRcFNvejExdDVhMmxnUDQ1cnZ5QW9YdnI5d3A3bWhIZ1lxM2FfbHYteUtzci1aTVA0UDZ2R0RrSDJZZS1OaFN2UGl3U1FpZVk?oc=5", "source_name": "The Business Times", "published_at": "2025-06-28T07:00:00+00:00", "published_display": "28 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System (0867.HK) Acquires a Dermatology Specialty Company: A Tough Player the Race", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPQkVnYVhGU1ZVbngyQXhqSVhqMXpxZ19RUjUxMUdYT1VScUw4S2xhdi01SzZrWkRkMTV4WGpXaEhrTC04bzZadHNPVFZDc3lNVEsyX2ZHS3B3eTdITjdkUjc5Y2VqUHQ0dHd1UTFDUzJMQmhUTjc0b29EUE12c3pVWGNxYWNfaUs3Tk5FRDc0YXNGRlFSUXZVajZFUlk5bUYzdml4WllMRFliUGlueG95WFd5VWxyak4zWGZKaEZPeHBjVEdoSTJoX214cUhEaEhTaDh6UTdfb1BVX083RnJHNmlLZ3lxZ0k?oc=5", "source_name": "ACN Newswire", "published_at": "2021-02-05T08:00:00+00:00", "published_display": "05 Feb 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why This China Drug Play Must Be in Your Portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNNjFhemtQay05V2tIc1NpS0NHWHZ2OHJaUGRuZXJycjNnVTBoV0g4Smw2LWpNRG03aFpDaldTRXpRWGJSLTcyS1RTc3NUUHlLOUNBR19MOXhzRVZ3QTdualNGX3JLZEVnM3FoY0t6UWREbm5yTm9XRnRiT0NUS3pITnBybGZKTkJvSnduU3BaTDE1THU2cnFKT1hPdUY?oc=5", "source_name": "Barron's", "published_at": "2015-09-24T07:00:00+00:00", "published_display": "24 Sep 2015 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "China Medical System Holdings Ltd. Actuals & Estimates (HKEX:867)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNMmVmVkQtRlNmbUhFNExDMjd3eGQzM091X0dHemhDQUZiWHQ3bXMwam5DdHBJUkVaaDlveElsWFdIMGxPekhmbGd6Q3ZVVnBLS0RNREtzaXpFMDhad1JudVZVczMwY3VuV3BZaDJVVks4UHZkY05hNzBXc2FXZldRSkRB?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T13:34:15+00:00", "published_display": "04 Jul 2026 13:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How NMPA Approval of First-in-Class Rabies Antibody Will Impact China Medical System (SEHK:867) Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxOWGFqVnA0OGJxWngtNVAxclVuZnZWNUtKZzYtZHhYZmhrMENkN25qR2RscV9yY3pSS09yVDhWTzFQdWhaLTVTX3k1Q3NMVF9pVWpZcFdrenVfdmdZdFFYSFBGY3ByVlhqYXFNMzl1Qi11Nk5NdDh4M2FGY2Y1dGNmSndZaWxFcWdSc3Z4VExKTXZvRXVFT3lpNFRoSktYOUFrZ1ZYNkVsVmxQZm0tdGpKUVlmblZkcENUeDJkQ19zZUloSy1RRzlGd3l5U3I2V1BpODIyRmVMRDcyM2FFSG9nbmgxOWFJNnRmb0RVWE5nLTBmQTFMU29GczF30gH_AUFVX3lxTE14TUptdHBtMXgwUG9qUFE0N3FqOUlWOXVZdDJHdU1JMzZQaUp3S2pmeDRLQ0V3NGxLYXYycHJwbzdqdERXczY3bkJFX2dnYWpRZW8weTdia2dwd3cwYnVEN2pKWVl4a3lRdjliQ0xkV2ZRMTNremhVanc0dDdYT2M1VllTRVdGaktyMF9rWXRKR29BX0lnTjVwdFZJcTc4djVXT0NFeWliVTJDR2J2MVMzWmlHN3RiMWlmRmcxQ2ZHdGt4UVVON3FiNndhN3h3cUUyNi03Q05kanB0RDZ1MS1iRWxJdlEzZDJESnJkTXNVUGRsbHdOeTE0cUF3VGJxbw?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System Holdings (SEHK:867) Stock Could Be Below Fair Value After CMS D008 Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxNQXBJdzBMZW1DSGNkMFA1N2ZMcXVWRDlFWUtXMXlGTjRkRnlLM3J4OEhTOGdVbkF5OUh2eDZ4WkNTUjNldDMtLVNpb2psU2pZRGlzYkV2Y2t5ZmFfWnk2Tl9BOHFCbTIzcDNtaGx3SW00aVZ3NnpfbklrcUpwcDJudFcwMjZadGV4MFBOX2F4NnozTjdpbHphQjMyMU5pOWM3RkZvVzA3cjZONHJaTy1OWTFIUjI0NE9qckVuYlB5R2oteVVpZzdQcnhxb2JBVzdES3ZiLWJFNkpReV9WRjRqWnhhN3JoR2hwUE5Id2I2LUVIeHhHMFJkQ0pR0gH_AUFVX3lxTE05R0lfSG40VVlWWWR1Z2l6Ql83a2luZVpWX3pIN2MzQXhrU0MzMGU1VXhtY3ljUk1KVDhRX0tPUGdrbVdELWFNVklTVjRPcEtuSUd3UGw0OUxsa296NVJSRGQzZXdIX0dEanBlWlA5NGVVWC1ZNVVodXF5THVqTU5scWJnQ2RPb1ZWeDBBMVc2TlVpUzhZRTFpejl4VldqWVBKTk5EUUVWMnR5NHlGT1ZPTVpZVjFqMWhGbFN0NHRnRmJreDRfdm5wYTJYNkZsOEdNQVQ2U0hPNFZjUjQ2ZlFodWVYdUNWbnVMTVdBYkV4RkdURzdfZlI0VTJfY1pvZw?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System Stock - analyst consensus and strategy snapshot", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPVTN2YUFybXJLUHpfeXBESDQtbWVjSHNsNUFDOTBYSHpHWGlfWVpFSUdqeWRiUUdZYnp1amNLbTE1STNWTm5aNTBydTJUb2ZwNTlCblROMUE3bU92blZVM3FxSGJKS3R6a0lseFZWaGlSX3V4VXhieUZYN0pMaXI5WENkYm1TaUFmRUJGUFpqeWtuNlhjN05LbjcwcTQxTkhLUzlsMThCT0d2X1pxM09ydDdWdkZuNzBkM2JtekpiOW1nZDg?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-17T15:29:30+00:00", "published_display": "17 Jun 2026 15:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zydus Lifesciences' Desidustat Receives NMPA Approval for Renal Anaemia Treatment in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxON0FEcU5fN19mdzhQbjY1cF81aHlJVU45UnlpajZKQkVVa3puSGVqcnlrNTB2bUxCdW9RSHQwSDZ3YjR5X21YakV2WDY0Y1pjb3psd2IwamtHR0xrV1BtVW9Mc0IyVXpqbEl6WVdmWi13NGlMMGNMd2VST1pzUkYwSW9HekE3R1dmNm9yeTVINGJOVmstNlBzRmNVb3h4MW82MjI1QU90empoNXhVcGhPLTVRUWhDU2ExMUdMa2k4cFIzaEVKam5seDFWeXY3TlZsdTc4anREZzJ4R2s2QUdr?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-15T07:00:00+00:00", "published_display": "15 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deloitte China assists listings of PATEO and HIPINE on SEHK", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOamZocWNsbkI2S19CeTZZd3JqamFRdGVpOEpmdXBJSGNBOGpHOTNUZk9GUnRrazFxMnB2UU9ocXBva3l3TThMQ2NuOU1YaTJ0ajVwSlpQSHZjblBoakwtaVVNV1JNNW9GZnkxdzVYdDlvVDBZVEJWNVZfSnJHd0Y4TzFIMkswcW9ERkpOSUY0V1h1RXQ3bkplUnpuNTF3VXFTRjItdTRPTQ?oc=5", "source_name": "Deloitte", "published_at": "2025-09-30T12:42:17+00:00", "published_display": "30 Sep 2025 12:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deloitte China assists dual-primary listing of Hesai Group in SEHK", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPREpOdk5PUmZLZ3pZZTlySkdaR1ZtaDdBdGxsSzVFVnNleWdZVHc3UXZRc2hfdU1YQjJWYWJ6VjNVUk9Nd2s3cUVTcDV6Sm1WaEQ3N1Q1eFBzM0JTbEpQbjQ2MjNPQURNNnIyMGZVbUZkNTlGTkdhaWFwZlMxclg2Z2xkUmxjamx3YTJadjY4dVR0RXVwTkNDZG9iX0c3cXhpcVlrT2FwdVB6aEItQW1qYm1LaS1YS19vVnBB?oc=5", "source_name": "Deloitte", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System\u2019s Alzheimer\u2019s Drug ZUNVYL Gains Approval in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPVXNfTU1sWnZpVXdMcjFySU9SNW92ajBmRGc5MzlxYTRUWGt0MmNLdkY1eEQ2VU5KY3J5emoxWjNDX2pGN1NUOEFlWFVISU0zLXJkeGE1cFVmNUYzdlBHZFFQdFV1bnJIcWcydVpXbTdacVBHcV9NOUlUbW1uMDlRemdxeENpRjJCSVJtRFVtR3prbkh1cEhweW5YYnF0SElrLTU1dXRBRmFOZ1Jwb3loLXhoTHdHV1V4R3ZoRQ?oc=5", "source_name": "TipRanks", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System debuts on SGX", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE11eWNVRHd5UFNIeGVKQlp6XzBzc0ZaR0ozdzZYYlhrYXRObXh3cUY2V2FvWHNjaTFBcWxZS2FlWTFubzd1WUphUzBxcTV4ZW1RQk1nalMwcmhhZmVQSlBEaFJPNUtKUmN0OEYxbWlWN29lQ2xna3dRLUZuc2JEQQ?oc=5", "source_name": "Singapore Business Review", "published_at": "2025-07-16T07:00:00+00:00", "published_display": "16 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System shares surge 11% with its secondary listing on SGX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPejNZbHk4UWJGcnNoRE9TUjZMU0E2cVRwTS1CS0JvS3FDMjBUUEZ2akxlY2oybG81aG4tbjFZdjRJRVhGWEtVeWdJQW0wUGkzNkZQVlkyUHFxajQzeGVVY3gtTE1OY3VDd3VPZVBQYXp0TUV0eVBDQ25HSWxnakJXaGZQMTJXYVZqT25ySmU4Q1hKVGQ0SjdkOXRmNFVXVTR3WU9LUGF4Vjg2WTdrcFhkdmRmdw?oc=5", "source_name": "The Business Times", "published_at": "2025-07-15T07:00:00+00:00", "published_display": "15 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System shares rise 11% with its secondary listing on SGX", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQZWNiWTdDeTBMWnFRSGVnX3BEWnlSTElfa3A2Q0hVOTVJbVJkMFNFM1lrWFJKcURqdFBvTEhoUy1OX2JoTjZXcElCdmJEWXl6cnU4Ykw3cjcwSDhqU2hkQmxRQXBWdkRMMkthY1RMcEgwd1Y0S1NJOGxULXdHQnpiMkRONl9HSVlZVTJPVTZYVlNoQzNqN044QU5Takw2VHpRaUtZM3dmVHo2UVVjem9xeGVrY2pGa0tmd0xqdVo2YjdNTlFa?oc=5", "source_name": "The Straits Times", "published_at": "2025-07-15T07:00:00+00:00", "published_display": "15 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deloitte China assists secondary listing of China Medical System on SGX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPTkVMSVpWMGlLcW8tQTEzY0tOcVhVdFRsTW9tR0tFOTN0LUhxWTc0ZVJURWdCNUdwVzVwSk5sUW1ZdVdtN25MeGxGNXBtTGVMbzNUZEctWjFXYnpEOVlneUdZa08wNmoyT29GeUV2UENwQVh6aC12VlpkVXNuNmx4TkVtV0ROcXgzSTlaM1dNVW1paW92ZXVxVWotV2gyWm9QOGxuelBEc3BSbjZybDBZS2dsNVdvaWdQNXFhblZVZnY2dw?oc=5", "source_name": "Deloitte", "published_at": "2025-07-15T07:00:00+00:00", "published_display": "15 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System eyes secondary listing on SGX in July", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPLXdCU3Y0QzZabGd3Q3lOSlp2VHlwRnRIV3FjNzFseXF2MFR0SVBjeFdMN1ZvdjFxOWFPY00wdkdETmFqNmhOdGV2OENDcjhRRWlEODdHcDRNLXdINUc2TmZSZGN4WV9scW5GR2lwR3Y3M1p6V3V0eUswdVdGRDdFQmpPWEJHMGZqZko0eUlnNnozWnAtWm1yQnA1V0U2QQ?oc=5", "source_name": "Singapore Business Review", "published_at": "2025-06-30T07:00:00+00:00", "published_display": "30 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong-listed China Medical System seeks secondary listing on SGX", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPODR3SE80RWJwMl9jd1RCTmlpOWY5SWVtX0FWdl91a2MzcXduLVRQSGhPOFQ5bTZPVE4ycmpzZFRuRTVPYV93WlJSbWN5cDdZVnhqTU4zVlktZHRoRWhjYUhyV0VXRUNVNUwweGJCNENRcFNvejExdDVhMmxnUDQ1cnZ5QW9YdnI5d3A3bWhIZ1lxM2FfbHYteUtzci1aTVA0UDZ2R0RrSDJZZS1OaFN2UGl3U1FpZVk?oc=5", "source_name": "The Business Times", "published_at": "2025-06-28T07:00:00+00:00", "published_display": "28 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Medical System (0867.HK) Acquires a Dermatology Specialty Company: A Tough Player the Race", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPQkVnYVhGU1ZVbngyQXhqSVhqMXpxZ19RUjUxMUdYT1VScUw4S2xhdi01SzZrWkRkMTV4WGpXaEhrTC04bzZadHNPVFZDc3lNVEsyX2ZHS3B3eTdITjdkUjc5Y2VqUHQ0dHd1UTFDUzJMQmhUTjc0b29EUE12c3pVWGNxYWNfaUs3Tk5FRDc0YXNGRlFSUXZVajZFUlk5bUYzdml4WllMRFliUGlueG95WFd5VWxyak4zWGZKaEZPeHBjVEdoSTJoX214cUhEaEhTaDh6UTdfb1BVX083RnJHNmlLZ3lxZ0k?oc=5", "source_name": "ACN Newswire", "published_at": "2021-02-05T08:00:00+00:00", "published_display": "05 Feb 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why This China Drug Play Must Be in Your Portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNNjFhemtQay05V2tIc1NpS0NHWHZ2OHJaUGRuZXJycjNnVTBoV0g4Smw2LWpNRG03aFpDaldTRXpRWGJSLTcyS1RTc3NUUHlLOUNBR19MOXhzRVZ3QTdualNGX3JLZEVnM3FoY0t6UWREbm5yTm9XRnRiT0NUS3pITnBybGZKTkJvSnduU3BaTDE1THU2cnFKT1hPdUY?oc=5", "source_name": "Barron's", "published_at": "2015-09-24T07:00:00+00:00", "published_display": "24 Sep 2015 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 58, "total_relevant": 16, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 14, "score": 52, "total": 16, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 87, "events": [{"event": "general", "label": "Market update", "weight": 6.95, "count": 12}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 11.9, "latest_week": "2026-07-10", "one_week_move": 3.2, "four_week_move": 8.2, "twelve_week_move": -13.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.783012, "market_dynamics_buy_signal": false, "relative_strength": -3.366325, "fair_value_gap": 15.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.3646, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.2% over one week, +8.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Deloitte", "count": 3}, {"label": "simplywall.st", "count": 2}, {"label": "Singapore Business Review", "count": 2}, {"label": "The Business Times", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "Ad Hoc News", "count": 1}, {"label": "scanx.trade", "count": 1}, {"label": "TipRanks", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 16}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Regulatory and legal", "count": 3}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "87/100 classification confidence."}, {"label": "Company focus", "value": "16", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.2% over one week, +8.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "China Medical System Holdings Ltd. Actuals & Estimates (HKEX:867)"}], "updated_at": "2026-07-17T23:59:58.973534+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}